Z. Gaci

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.

J. Grill, P. Maingon, J. Habrand, 2003, International journal of radiation oncology, biology, physics.

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

F. Penault-Llorca, P. Maingon, P. Romestaing, 2010, Critical reviews in oncology/hematology.

Quality assurance of a French multicentric conformal radiotherapy protocol for low-stage medulloblastoma : variability in target volume delineation

X. Muracciole, C. Carrie, M. Baron, 2002 .

Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.

P. Ingrand, M. Bouin-Pineau, A. Daban, 2001, International journal of oncology.

[Ductal carcinoma in situ: role of the boost].

I. Barillot, P. Maingon, A. Monnier, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.